-
1
-
-
0037809623
-
Costs of rheumatoid arthritis in Germany, a micro-costing approach based on healthcare payer's data sources
-
Ruof J, Hülsemann JL, Mittendorf T, Handelmann S, von der Schulenburg JM, Zeidler H, et al. Costs of rheumatoid arthritis in Germany, a micro-costing approach based on healthcare payer's data sources. Ann Rheum Dis 2003;62:544-50.
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 544-550
-
-
Ruof, J.1
Hülsemann, J.L.2
Mittendorf, T.3
Handelmann, S.4
Von Der Schulenburg, J.M.5
Zeidler, H.6
-
3
-
-
0034942556
-
Markers for work disability in rheumatoid arthritis
-
Sokka T, Pincus T. Markers for work disability in rheumatoid arthritis. J Rheumatol 2001;28:1718-22.
-
(2001)
J Rheumatol
, vol.28
, pp. 1718-1722
-
-
Sokka, T.1
Pincus, T.2
-
4
-
-
0036210887
-
Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS)
-
Young A, Dixey J, Kulinskaya E, Cox N, Davies P, Devlin J, et al. Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis 2002;61:335-40.
-
(2002)
Ann Rheum Dis
, vol.61
, pp. 335-340
-
-
Young, A.1
Dixey, J.2
Kulinskaya, E.3
Cox, N.4
Davies, P.5
Devlin, J.6
-
5
-
-
0142125198
-
Work disability in early rheumatoid arthritis
-
Sokka T. Work disability in early rheumatoid arthritis. Clin Exp Rheumatol 2003;21:571-4.
-
(2003)
Clin Exp Rheumatol
, vol.21
, pp. 571-574
-
-
Sokka, T.1
-
6
-
-
9144226973
-
Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis. A 5-year randomized followup trial
-
Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Korpela M, Julkunen H, et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis. A 5-year randomized followup trial. Arthritis Rheum 2004;50:55-62.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 55-62
-
-
Puolakka, K.1
Kautiainen, H.2
Möttönen, T.3
Hannonen, P.4
Korpela, M.5
Julkunen, H.6
-
7
-
-
0033535754
-
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial
-
FIN-RACo trial group
-
Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999;353:1568-73.
-
(1999)
Lancet
, vol.353
, pp. 1568-1573
-
-
Möttönen, T.1
Hannonen, P.2
Leirisalo-Repo, M.3
Nissilä, M.4
Kautiainen, H.5
Korpela, M.6
-
9
-
-
0021993033
-
A Wilcoxon-type test for trend
-
Cuzick J. A Wilcoxon-type test for trend. Statistics Med 1985;4:87-9.
-
(1985)
Statistics Med
, vol.4
, pp. 87-89
-
-
Cuzick, J.1
-
10
-
-
0028793834
-
Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial
-
Buchbinder R, Bombardier C, Yeung M, Tugwell P. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial. Arthritis Rheum 1995;38:1568-80.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 1568-1580
-
-
Buchbinder, R.1
Bombardier, C.2
Yeung, M.3
Tugwell, P.4
-
11
-
-
0025934433
-
The assessment and prediction of functional disability in rheumatoid arthritis
-
Wolfe F, Cathey M. The assessment and prediction of functional disability in rheumatoid arthritis. J Rheumatol 1991;18:1298-306.
-
(1991)
J Rheumatol
, vol.18
, pp. 1298-1306
-
-
Wolfe, F.1
Cathey, M.2
-
12
-
-
0037334584
-
An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial
-
Pincus T, Strand V, Koch G, Amara I, Crawford B, Wolfe F, et al. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum 2003;48:625-30.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 625-630
-
-
Pincus, T.1
Strand, V.2
Koch, G.3
Amara, I.4
Crawford, B.5
Wolfe, F.6
-
13
-
-
0023252022
-
The work dynamics of the person with rheumatoid arthritis
-
Yelin E, Henke C, Epstein W. The work dynamics of the person with rheumatoid arthritis. Arthritis Rheum 1987;30:507-12.
-
(1987)
Arthritis Rheum
, vol.30
, pp. 507-512
-
-
Yelin, E.1
Henke, C.2
Epstein, W.3
-
14
-
-
0034897472
-
Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis
-
Kuiper S, van Gestel AM, Swinkels HL, de Boo TM, da Silva JA, van Riel PLCM. Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol 2001;28:1809-16.
-
(2001)
J Rheumatol
, vol.28
, pp. 1809-1816
-
-
Kuiper, S.1
Van Gestel, A.M.2
Swinkels, H.L.3
De Boo, T.M.4
Da Silva, J.A.5
Van Riel, P.L.C.M.6
|